Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review Article
  • Published:

Procalcitonin versus C-reactive protein: review of kinetics and performance for diagnosis of neonatal sepsis

Journal of Perinatology volume 39, pages 893–903 (2019)Cite this article

Subjects

Abstract

Procalcitonin (PCT) and C-reactive protein (CRP) are commonly used biomarkers, but their diagnostic advantage for neonatal early-onset (EOS) or late-onset (LOS) sepsis is controversial. In a comprehensive literature review we found significant heterogeneity between studies in sample timing, cut-off values, consideration of blood culture results for sepsis classification, and definition of EOS versus LOS. We identified 39 studies directly comparing PCT with CRP, but only four in very low birth weight (VLBW) neonates. The mean sensitivity for EOS, LOS, and EOS + LOS was 73.6%, 88.9%, and 76.5% for PCT, compared to 65.6%, 77.4%, and 66.4% for CRP, respectively. Mean specificity of PCT and CRP was 82.8% versus 82.7% for EOS, 75.6% versus 81.7% for LOS, and 80.4% versus 91.3% for EOS + LOS. More studies directly comparing both biomarkers for EOS and LOS, especially in extremely and very-low-birth-weight infants, are needed to determine their clinical value for guidance of antibiotic therapy in neonatal sepsis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1

Similar content being viewed by others

References

  1. Cortese F, Scicchitano P, Gesualdo M, Filaninno A, De Giorgi E, Schettini F, et al. Early and late infections in newborns: where do we stand? A review. Pediatr Neonatol. 2016;57:265–73.

    PubMed  Google Scholar 

  2. Vergnano S, Sharland M, Kazembe P, Mwansambo C, Heath PT. Neonatal sepsis: an international perspective. Arch Dis Child Fetal Neonatal Ed. 2005;90:F220–4.

    CAS  PubMed  PubMed Central  Google Scholar 

  3. Stoll BJ, Hansen NI, Higgins RD, Fanaroff AA, Duara S, Goldberg R, et al. Very low birth weight preterm infants with early onset neonatal sepsis: the predominance of gram-negative infections continues in the National Institute of Child Health and Human Development Neonatal Research Network, 2002–2003. Pediatr Infect Dis J. 2005;24:635–9.

    PubMed  Google Scholar 

  4. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics. 2002;110:285–91.

    Article  PubMed  Google Scholar 

  5. Cantey JB, Wozniak PS, Pruszynski JE, Sánchez PJ. Reducing unnecessary antibiotic use in the neonatal intensive care unit (SCOUT): a prospective interrupted time-series study. Lancet Infect Dis. 2016;16:1178–84.

    PubMed  Google Scholar 

  6. Klingenberg C, Kornelisse RF, Buonocore G, Maier RF, Stocker M. Culture-negative early-onset neonatal sepsis—at the crossroad between efficient sepsis care and antimicrobial stewardship. Front Pediatr. 2018;6:285.

    PubMed  PubMed Central  Google Scholar 

  7. Thaver D, Zaidi AK. Burden of neonatal infections in developing countries: a review of evidence from community-based studies. Pediatr Infect Dis J. 2009;28:S3–9.

    PubMed  Google Scholar 

  8. Verstraete EH, Blot K, Mahieu L, Vogelaers D, Blot S. Prediction models for neonatal health care-associated sepsis: a meta-analysis. Pediatrics. 2015;135:e1002–e14.

    PubMed  Google Scholar 

  9. Zea-Vera A, Ochoa TJ. Challenges in the diagnosis and management of neonatal sepsis. J Trop Pediatr. 2015;61:1–13.

    PubMed  PubMed Central  Google Scholar 

  10. Schelonka R, Chai M, Yoder B, Hensley D, Brockett R, Ascher D. Volume of blood required to detect common neonatal pathogens. J Pediatr. 1996;129:275–8.

    CAS  PubMed  Google Scholar 

  11. Fjalstad JW, Stensvold HJ, Bergseng H, Simonsen GS, Salvesen B, Ronnestad AE, et al. Early-onset sepsis and antibiotic exposure in term infants: a nationwide population-based study in Norway. Pediatr Infect Dis J. 2016;35:1–6.

    PubMed  Google Scholar 

  12. Ehl S, Gering B, Bartmann P, Hogel J, Pohlandt F. C-reactive protein is a useful marker for guiding duration of antibiotic therapy in suspected neonatal bacterial infection. Pediatrics. 1997;99:216–21.

    CAS  PubMed  Google Scholar 

  13. Mukherjee A, Davidson L, Anguvaa L, Duffy DA, Kennea N. NICE neonatal early onset sepsis guidance: greater consistency, but more investigations, and greater length of stay. Arch Dis Child Fetal Neonatal Ed. 2015;100:F248–9.

    PubMed  Google Scholar 

  14. Stocker M, van Herk W, El Helou S, Dutta S, Fontana MS, Schuerman F, et al. Procalcitonin-guided decision making for duration of antibiotic therapy in neonates with suspected early-onset sepsis: a multicentre, randomised controlled trial (NeoPIns). Lancet. 2017;390:871–81.

    CAS  PubMed  Google Scholar 

  15. Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis. 2004;39:206–17.

    CAS  PubMed  Google Scholar 

  16. Xu L, Li Q, Mo Z, You P. Diagnostic value of C-reactive protein in neonatal sepsis: a meta-analysis. Eur J Inflamm. 2016;14:100–8.

    Google Scholar 

  17. Yu Z, Liu J, Sun Q, Qiu Y, Han S, Guo X. The accuracy of the procalcitonin test for the diagnosis of neonatal sepsis: a meta-analysis. Scand J Infect Dis. 2010;42:723–33.

    PubMed  Google Scholar 

  18. Rhodes B, Furnrohr BG, Vyse TJ. C-reactive protein in rheumatology: biology and genetics. Nat Rev Rheumatol. 2011;7:282–9.

    CAS  PubMed  Google Scholar 

  19. Black S, Kushner I, Samols D. C-reactive protein. J Biol Chem. 2004;279:48487–90.

    CAS  PubMed  Google Scholar 

  20. Hofer N, Zacharias E, Muller W, Resch B. An update on the use of C-reactive protein in early-onset neonatal sepsis: current insights and new tasks. Neonatology. 2012;102:25–36.

    CAS  PubMed  Google Scholar 

  21. Weitkamp J-H, Aschner J. Diagnostic use of C-reactive protein (CRP) in assessment of neonatal sepsis. NeoReviews. 2005;6:e508–e15.

    Google Scholar 

  22. Reinhart K, Meisner M, Brunkhorst FM. Markers for sepsis diagnosis: what is useful? Crit Care Clin. 2006;22:503–19, ix–x.

    CAS  PubMed  Google Scholar 

  23. Muller B, White JC, Nylen ES, Snider RH, Becker KL, Habener JF. Ubiquitous expression of the calcitonin-i gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab. 2001;86:396–404.

    CAS  PubMed  Google Scholar 

  24. Christ-Crain M, Muller B. Procalcitonin in bacterial infections—hype, hope, more or less? Swiss Med Wkly. 2005;135:451–60.

    CAS  PubMed  Google Scholar 

  25. Oberhoffer M, Stonans I, Russwurm S, Stonane E, Vogelsang H, Junker U, et al. Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis-related cytokines in vitro. J Lab Clin Med. 1999;134:49–55.

    CAS  PubMed  Google Scholar 

  26. Balog A, Ocsovszki I, Mandi Y. Flow cytometric analysis of procalcitonin expression in human monocytes and granulocytes. Immunol Lett. 2002;84:199–203.

    CAS  PubMed  Google Scholar 

  27. Wiedermann FJ, Kaneider N, Egger P, Tiefenthaler W, Wiedermann CJ, Lindner KH, et al. Migration of human monocytes in response to procalcitonin. Crit Care Med. 2002;30:1112–7.

    CAS  PubMed  Google Scholar 

  28. Meisner M. Pathobiochemistry and clinical use of procalcitonin. Clin Chim Acta. 2002;323:17–29.

    CAS  PubMed  Google Scholar 

  29. Chiesa C, Pellegrini G, Panero A, Osborn JF, Signore F, Assumma M, et al. C-reactive protein, interleukin-6, and procalcitonin in the immediate postnatal period: influence of illness severity, risk status, antenatal and perinatal complications, and infection. Clin Chem. 2003;49:60–8.

    CAS  PubMed  Google Scholar 

  30. Assumma M, Signore F, Pacifico L, Rossi N, Osborn JF, Chiesa C. Serum procalcitonin concentrations in term delivering mothers and their healthy offspring: a longitudinal study. Clin Chem. 2000;46:1583–7.

    CAS  PubMed  Google Scholar 

  31. Mjelle AB, Guthe HJT, Reigstad H, Bjorke-Monsen AL, Markestad T. Serum concentrations of C-reactive protein in healthy term-born Norwegian infants 48–72 h after birth. Acta Paediatr. 2018. https://doi.org/10.1111/apa.14578. [Epub ahead of print]

    PubMed  Google Scholar 

  32. Kaapa P, Koistinen E. Maternal and neonatal C-reactive protein after interventions during delivery. Acta Obstet Gynecol Scand. 1993;72:543–6.

    CAS  PubMed  Google Scholar 

  33. Franz AKM, Pohlandt F, Steinbach G. Comparison of procalcitonin with interleukin 8, C-reactive protein and differential white blood cell count for the early diagnosis of bacterial infections in newborn infants. Pediatr Infect Dis J. 1999;18:666–71.

    CAS  PubMed  Google Scholar 

  34. Franz ASG, Kron M, Pohlandt F. Reduction of unnecessary antibiotic therapy in newborn infants using interleukin-8 and C-reactive protein as markers of bacterial infections. Pediatrics. 1999;104:447–53.

    CAS  PubMed  Google Scholar 

  35. Yan ST, Sun LC, Jia HB, Gao W, Yang JP, Zhang GQ. Procalcitonin levels in bloodstream infections caused by different sources and species of bacteria. Am J Emerg Med. 2017;35:579–83.

    PubMed  Google Scholar 

  36. Gendrel D, Raymond J, Coste J, Moulin F, Lorrot M, Guerin S, et al. Comparison of procalcitonin with C-reactive protein, interleukin 6 and interferon-alpha for differentiation of bacterial vs. viral infections. Pediatr Infect Dis J. 1999;18:875–81.

    CAS  PubMed  Google Scholar 

  37. Meisner M, Tschaikowsky K, Palmaers T, Schmidt J. Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS. Crit Care. 1999;3:45–50.

    CAS  PubMed  PubMed Central  Google Scholar 

  38. Milcent K, Faesch S, Gras-Le Guen C, Dubos F, Poulalhon C, Badier I, et al. Use of procalcitonin assays to predict serious bacterial infection in young febrile infants. JAMA Pediatr. 2016;170:62–9.

    PubMed  Google Scholar 

  39. Bolke E, Jehle PM, Trautmann M, Gotz I, Krebs B, Steinbach G, et al. Different acute-phase response in newborns and infants undergoing surgery. Pediatr Res. 2002;51:333–8.

    PubMed  Google Scholar 

  40. Arkader R, Troster EJ, Abellan DM, Lopes MR, Junior RR, Carcillo JA, et al. Procalcitonin and C-reactive protein kinetics in postoperative pediatric cardiac surgical patients. J Cardiothorac Vasc Anesth. 2004;18:160–5.

    CAS  PubMed  Google Scholar 

  41. Celik IH, Yilmaz Y, Erdeve O, Demirel G, Oguz SS, Uras N, et al. The acute-phase response in differentiating sepsis from inflammation in neonates who require abdominal surgery. Acta Chir Belg. 2012;112:292–6.

    CAS  PubMed  Google Scholar 

  42. Neunhoeffer F, Plinke S, Renk H, Hofbeck M, Fuchs J, Kumpf M, et al. Serum concentrations of interleukin-6, procalcitonin, and C-reactive protein: discrimination of septical complications and systemic inflammatory response syndrome after pediatric surgery. Eur J Pediatr Surg. 2016;26:180–5.

    PubMed  Google Scholar 

  43. Pavcnik-Arnol M, Bonac B, Groselj-Grenc M, Derganc M. Changes in serum procalcitonin, interleukin 6, interleukin 8 and C-reactive protein in neonates after surgery. Eur J Pediatr Surg. 2010;20:262–6.

    CAS  PubMed  Google Scholar 

  44. Chiesa C, Natale F, Pascone R, Osborn JF, Pacifico L, Bonci E, et al. C reactive protein and procalcitonin: reference intervals for preterm and term newborns during the early neonatal period. Clin Chim Acta. 2011;412:1053–9.

    CAS  PubMed  Google Scholar 

  45. Fukuzumi N, Osawa K, Sato I, Iwatani S, Ishino R, Hayashi N, et al. Age-specific percentile-based reference curve of serum procalcitonin concentrations in Japanese preterm infants. Sci Rep. 2016;6:23871.

    CAS  PubMed  PubMed Central  Google Scholar 

  46. Turner D, Hammerman C, Rudensky B, Schlesinger Y, Goia C, Schimmel MS. Procalcitonin in preterm infants during the first few days of life: introducing an age related nomogram. Arch Dis Child Fetal Neonatal Ed. 2006;91:F283–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  47. Hahn WH, Song JH, Park IS, Kim H, Park S, Oh MH. Reference intervals of serum procalcitonin are affected by postnatal age in very low birth weight infants during the first 60 days after birth. Neonatology . 2015;108:60–4.

    CAS  PubMed  Google Scholar 

  48. Benitz W, Han, M., Madan, A., Ramachandra, P. Serial serum C-reactive protein levels in the diagnosis of neonatal infection. Pediatrics. 1998;102:e41.

    CAS  PubMed  Google Scholar 

  49. Beltempo M, Viel-Theriault I, Thibeault R, Julien AS, Piedboeuf B. C-reactive protein for late-onset sepsis diagnosis in very low birth weight infants. BMC Pediatr. 2018;18:16.

    PubMed  PubMed Central  Google Scholar 

  50. Pavcnik-Arnol M, Hojker S, Derganc M. Lipopolysaccharide-binding protein, lipopolysaccharide, and soluble CD14 in sepsis of critically ill neonates and children. Intensive Care Med. 2007;33:1025–32.

    CAS  PubMed  Google Scholar 

  51. Soh A, Binder L, Clough M, Hernandez MH, Lefèvre G, Mostert K, et al. Comparison of the novel ARCHITECT procalcitonin assay with established procalcitonin assay systems. Pract Lab Med. 2018;12:e00110.

    CAS  PubMed  PubMed Central  Google Scholar 

  52. Chambliss AB, Hayden J, Colby JM. Evaluation of procalcitonin immunoassay concordance near clinical decision points. Clin Chem Lab Med. 2019. https://doi.org/10.1515/cclm-2018-1362. [Epub ahead of print].

  53. Al-Zahrani A, Ghonaim MM, Hussein YM, Eed EM, Khalifa AS, Dorgham LS. Evaluation of recent methods versus conventional methods for diagnosis of early-onset neonatal sepsis. J Infect Dev Ctries. 2015;9:388–93.

    CAS  PubMed  Google Scholar 

  54. Naher BS MM, Noor K, Shahiddullah M. Role of serum procalcitonin and C-reactive protein in the diagnosis of neonatal sepsis. Bangladesh Med Res Counc Bull. 2011;37:40–6.

    PubMed  Google Scholar 

  55. Guibourdenche J, Bedu A, Petzold L, Marchand M, Mariani-Kurdjian P, Hurtaud-Roux MF, et al. Biochemical markers of neonatal sepsis: value of procalcitonin in the emergency setting. Ann Clin Biochem. 2002;39(Pt 2):130–5.

    CAS  PubMed  Google Scholar 

  56. Canpolat FE, Yigit S, Korkmaz A, Yurdakok M, Tekinalp G. Procalcitonin versus CRP as an early indicator of fetal infection in preterm premature rupture of membranes. Turk J Pediatr. 2011;53:180–6.

    PubMed  Google Scholar 

  57. Resch BGW, Muller WD. Procalcitonin and interleukin-6 in the diagnosis of early-onset sepsis of the neonate. Acta Paediatr. 2003;92:243–5.

    CAS  PubMed  Google Scholar 

  58. Koksal N, Harmanci R, Cetinkaya M, Hacimustafaoglu M. Role of procalcitonin and CRP in diagnosis and follow-up of neonatal sepsis. Turk J Pediatr. 2007;49:21–9.

    PubMed  Google Scholar 

  59. Altunhan H, Annagur A, Ors R, Mehmetoglu I. Procalcitonin measurement at 24 h of age may be helpful in the prompt diagnosis of early-onset neonatal sepsis. Int J Infect Dis. 2011;15:e854–8.

    CAS  PubMed  Google Scholar 

  60. Mohsen AH, Kamel BA. Predictive values for procalcitonin in the diagnosis of neonatal sepsis. Electron Physician. 2015;7:1190–5.

    PubMed  PubMed Central  Google Scholar 

  61. Schlapbach LJ, Graff R, Woerner A, Fontana M, Zimmermann-Baer U, Glauser D, et al. Pancreatic stone protein as a novel marker for neonatal sepsis. Intensive Care Med. 2013;39:754–63.

    CAS  PubMed  Google Scholar 

  62. Abd Elmouttaleb HAA AshrafT, Bayomy EbrahimM, Abdelhamed MohamedR, Esmael NabilF. Plasma procalcitonin and proadrenomedullin concentrations as predictive markers for early onset neonatal sepsis. Am J Biochem. 2016;6:6–15.

    Google Scholar 

  63. Park IH, Lee SH, Yu ST, Oh YK. Serum procalcitonin as a diagnostic marker of neonatal sepsis. Korean J Pediatr. 2014;57:451–6.

    PubMed  PubMed Central  Google Scholar 

  64. Fendler WM, Piotrowski AJ. Procalcitonin in the early diagnosis of nosocomial sepsis in preterm neonates. J Paediatr Child Health. 2008;44:114–8.

    PubMed  Google Scholar 

  65. Vazzalwar R, Pina-Rodrigues E, Puppala BL, Angst DB, Schweig L. Procalcitonin as a screening test for late-onset sepsis in preterm very low birth weight infants. J Perinatol. 2005;25:397–402.

    CAS  PubMed  Google Scholar 

  66. Ucar B, Yildiz B, Aksit MA, Yarar C, Colak O, Akbay Y, et al. Serum amyloid A, procalcitonin, tumor necrosis factor-alpha, and interleukin-1beta levels in neonatal late-onset sepsis. Mediat Inflamm. 2008;2008:737141.

    Google Scholar 

  67. Ertuğrul S, Annagur A, Kurban S, Altunhan H, Ors R. Comparison of urinary neutrophil gelatinase-associated lipocalin, C-reactive protein and procalcitonin in the diagnosis of late onset sepsis in preterm newborns. J Matern Fetal Neonatal Med. 2013;26:430–3.

    PubMed  Google Scholar 

  68. Jacquot A, Labaune JM, Baum TP, Putet G, Picaud JC. Rapid quantitative procalcitonin measurement to diagnose nosocomial infections in newborns. Arch Dis Child Fetal Neonatal Ed. 2009;94:F345–8.

    CAS  PubMed  Google Scholar 

  69. Bohnhorst B, Lange M, Bartels DB, Bejo L, Hoy L, Peter C. Procalcitonin and valuable clinical symptoms in the early detection of neonatal late-onset bacterial infection. Acta Paediatr. 2012;101:19–25.

    CAS  PubMed  Google Scholar 

  70. Distefano G, Curreri R, Betta P, Romeo MG, Amato M. Procalcitonin serum levels in perinatal bacterial and fungal infection of preterm infants. Acta Paediatr. 2004;93:216–9.

    CAS  PubMed  Google Scholar 

  71. Verboon-Maciolek MA, Thijsen SF, Hemels MA, Menses M, van Loon AM, Krediet TG, et al. Inflammatory mediators for the diagnosis and treatment of sepsis in early infancy. Pediatr Res. 2006;59:457–61.

    CAS  PubMed  Google Scholar 

  72. Enguix A, Rey C, Concha A, Medina A, Coto D, Diéguez MA. Comparison of procalcitonin with C-reactive protein and serum amyloid for the early diagnosis of bacterial sepsis in critically ill neonates and children. Intensive Care Med. 2000;27:211–5.

    Google Scholar 

  73. Turner D, Hammerman C, Rudensky B, Schlesinger Y, Schimmel MS. The role of procalcitonin as a predictor of nosocomial sepsis in preterm infants. Acta Paediatr. 2006;95:1571–6.

    PubMed  Google Scholar 

  74. Bustos BR, Araneda CH. Procalcitonin for the diagnosis of late onset sepsis in newborns of very low birth weight. Rev Chil Infectol. 2012;29:511–6.

    Google Scholar 

  75. Celik HT, Portakal O, Yigit S, Hascelik G, Korkmaz A, Yurdakok M. Efficacy of new leukocyte parameters versus serum C-reactive protein, procalcitonin, and interleukin-6 in the diagnosis of neonatal sepsis. Pediatr Int. 2016;58:119–25.

    CAS  PubMed  Google Scholar 

  76. Pravin Charles MV, Kalaivani R, Venkatesh S, Kali A, Seetha KS. Evaluation of procalcitonin as a diagnostic marker in neonatal sepsis. Indian J Pathol Microbiol. 2018;61:81–4.

    PubMed  Google Scholar 

  77. Sakha K, Husseini MB, Seyyedsadri N. The role of the procalcitonin in diagnosis of neonatal sepsis and correlation between procalcitonin and C-reactive protein in these patients. Pak J Biol Sci. 2008;11:1785–90.

    CAS  PubMed  Google Scholar 

  78. Cetinkaya M, Ozkan H, Koksal N, Celebi S, Hacimustafaoglu M. Comparison of serum amyloid A concentrations with those of C-reactive protein and procalcitonin in diagnosis and follow-up of neonatal sepsis in premature infants. J Perinatol. 2009;29:225–31.

    CAS  PubMed  Google Scholar 

  79. Rashwan NI, Hassan MH, Mohey El-Deen ZM, Ahmed AE. Validity of biomarkers in screening for neonatal sepsis—a single center-hospital based study. Pediatr Neonatol. 2018;S1875-9572:30647–2. piihttps://doi.org/10.1016/j.pedneo.2018.05.001. [Epub ahead of print]

    Google Scholar 

  80. Cekmez F, Canpolat FE, Cetinkaya M, Aydinoz S, Aydemir G, Karademir F, et al. Diagnostic value of resistin and visfatin, in comparison with C-reactive protein, procalcitonin and interleukin-6 in neonatal sepsis. Eur Cytokine Netw. 2011;22:113–7.

    CAS  PubMed  Google Scholar 

  81. Boo NY, Nor Azlina AA, Rohana J. Usefulness of a semi-quantitative procalcitonin test kit for early diagnosis of neonatal sepsis. Singap Med J. 2008;49:204–8.

    CAS  Google Scholar 

  82. Kocabas E, Sarikcioglu A, Aksaray N, Seydaoglu G, Seyhun Y, Yaman A. Role of procalcitonin, C-reactive protein, interleukin-6, interleukin-8 and tumor necrosis factor-alpha in the diagnosis of neonatal sepsis. Turk J Pediatr. 2007;49:7–20.

    PubMed  Google Scholar 

  83. Chiesa C, Panero A, Rossi N, Stegagno M, De Giusti M, Osborn JF, et al. Reliability of procalcitonin concentrations for the diagnosis of sepsis in critically ill neonates. Clin Infect Dis. 1998;26:664–72.

    CAS  PubMed  Google Scholar 

  84. Groselj-Grenc M, Ihan A, Pavcnik-Arnol M, Kopitar AN, Gmeiner-Stopar T, Derganc M. Neutrophil and monocyte CD64 indexes, lipopolysaccharide-binding protein, procalcitonin and C-reactive protein in sepsis of critically ill neonates and children. Intensive Care Med. 2009;35:1950–8.

    CAS  PubMed  Google Scholar 

  85. Adib M, Bakhshiani Z, Navaei F, Saheb Fosoul F, Fouladi S, Kazemzadeh H. Procalcitonin: a reliable marker for the diagnosis of neonatal sepsis. Iran J Basic Med Sci. 2012;15:777–82.

    CAS  PubMed  PubMed Central  Google Scholar 

  86. Bonac B, Derganc, M., Wraber, B., Hojker, S. Interleukin-8 and procalcitonin in early diagnosis of early severe bacterial infection in critically ill neonates. Eur J Physiol. 2000;440:R72–R4.

    PubMed  Google Scholar 

  87. Blommendahl J, Janas M, Laine S, Miettinen A, Ashorn P. Comparison of procalcitonin with CRP and differential white blood cell count for diagnosis of culture-proven neonatal sepsis. Scand J Infect Dis. 2009;34:620–2.

    Google Scholar 

  88. Kumar N, Dayal R, Singh P, Pathak S, Pooniya V, Goyal A, et al. A comparative evaluation of presepsin with procalcitonin and CRP in diagnosing neonatal sepsis. Indian J Pediatr. 2018. https://doi.org/10.1007/s12098-018-2659-3. [Epub ahead of print].

    PubMed  Google Scholar 

Download references

Acknowledgements

We apologize to the authors whose work we were not able to include due to space limitations.

Author information

Authors and Affiliations

  1. Department of Pediatrics, Mildred Stahlman Divison of Neonatology, Vanderbilt University Medical Center, Monroe Carrol Jr. Children’s Hospital, Nashville, TN, USA

    Samantha Eschborn & Joern-Hendrik Weitkamp

Authors
  1. Samantha Eschborn
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joern-Hendrik Weitkamp
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Joern-Hendrik Weitkamp.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Eschborn, S., Weitkamp, JH. Procalcitonin versus C-reactive protein: review of kinetics and performance for diagnosis of neonatal sepsis. J Perinatol 39, 893–903 (2019). https://doi.org/10.1038/s41372-019-0363-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41372-019-0363-4

This article is cited by

Search

Advanced search

Quick links